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Background. Toll-like receptors (TLRs) represent a family of evolutionarily conserved proteins, that represent a fundamental link
between innate and adaptive immune responses. Aim. The purpose of this study was to investigate the expression of TLR4 and
TLR9 in the normal nasal mucosa and in the mucosa of subjects with diﬀerent phenotypes of rhinitis. Methodology.Ac o n f o c a l
analysisofTLR4andTLR9(co)expressionwascarriedoutonbiopsiesfromtheinferiorturbinateobtainedfrom4patientsaﬀected
by persistent allergic rhinitis, 8 patients with chronic rhino-sinusitis, and 6 patients with vasomotor rhinitis The results were
compared with those of specimens obtained from 4 subjects undergoing nasal surgery, but with signs of nasal inﬂammation.
Results. TLR4 and TLR9 were expressed in the healthy nasal mucosa; TLR4 and TLR9 expression was signiﬁcantly decreased in
allergic rhinitis. TLR4 was over expressed in the epithelium of chronic rhino-sinusitis. Both TLRs were co-expressed in the sub-
epithelial inﬁltrate of chronic and vasomotor rhinitis, even though this expression was higher in the former compared with the
latter. Conclusions. This study indicates that TLR4 and TLR9 show a diﬀerent pattern of expression in diﬀerent phenotypes of
rhinitis, possibly related to the type and severity of the disease.
1.Introduction
Innateimmunityplaysaselectiveandspeciﬁcroleindestroy-
ing pathogens and presenting antigens to the cells involved
in adaptive immune response [1, 2]. The discrimination be-
tween self- and foreign pathogens is mainly mediated by a
family of receptors—termed pattern recognition receptors,
(PRRs)—which interact with speciﬁc ligands of the invading
hosts (pathogen-associated molecular proteins (PAMPs))
[1]. PRRs are mainly expressed by epithelial cells, antigen-
presenting cells,regulatoryTcells,andothercellsinvolved in
theinteractionbetweentheimmunesystemandtheenviron-
ment [3–5]. Toll-like receptors (TLRs) represent the major
family of PRRs—represented at present by 13 members in
humans, TLR1 to TLR13, whose localization correlates to
some extent with the molecular patterns of their ligands. In
particular, TLR1, TLR2, and TLR4 are located on the cellular
surface, while TLR3, TLR7 and TLR9 are not expressed on
the cell surface as they are involved in the recognition of nu-
cleic-acid-like structures [6]. TLRs activation triggers a cas-
cade of reactions leading to increased expression of proin-
ﬂammatory genes [7]. As recently reported, TLR signalling
aﬀects the development of several human diseases such as
bacterial infections, sepsis, immunodeﬁciencies, and asthma
and autoimmune diseases [8].
The aim of the present study was to investigate the exp-
ression of TLR4 and TLR9 in the healthy and inﬂammatory
nasal mucosa of diﬀerent rhinitis phenotypes, by means of
confocal analysis on paraﬃn sections of the inferior turbi-
nates.
2.MaterialsandMethods
2.1. Reagents. All reagents used in this study were of an-
alytical grade and purchased from EuroClone (Milan, Italy)2 International Journal of Otolaryngology
or ICN Biomedicals (Costa Mesa, CA, USA). All sterile
plastic ware was from NUNC (Roskilde, Denmark).
2.2. Patients and Tissue Sampling. After informed consent
and approval from a local ethic committee, paraﬃns e c t i o n s
of the inferior turbinate were obtained from 4 patients suf-
fering from seasonal nasal allergy, 8 patients with chronic
rhinosinusitis, and 6 patients aﬀected by vasomotor rhinitis,.
Normal sections (referred to as control) were obtained from
4 subjects undergoing nasal surgery with no acute or chronic
nasal inﬂammation. Each biopsy was ﬁxed in 10% formalin
and routinely processed for basic histology or confocal mi-
croscopy.
2.3. Confocal Analysis. Serial sections were prepared accord-
ing to a routine procedure for histological and immunoﬂuo-
rescent evaluation, including a paraﬃn inclusion and dewax
steps,toprovide5µmsections.Slideswerepreincubated(3%
bovine serum albumin and 0.5% Triton X-100 in 10mM in
buﬀered phosphate saline, pH 7.5; PBS) and then incubated
overnight at 4◦C with a cocktail of the following antibodies:
rabbit anti-human TLR4 (4µg/mL) and goat anti-human
TLR9 antibodies (2µg/mL), purchased from Santa Cruz
Biotech (Santa Cruz, CA). Speciﬁc binding of the primary
antibodies was detected using secondary species-speciﬁc
Cy32-conjugatedanti-rabbit(forTLR4)andCy3-conjugated
anti-goat (for TLR9), all prediluted 1/200 in PBS containing
0.05% Tween-20 and incubated at room temperature for
45 minutes (Jackson ImmunoResearch Laboratories, West
Grove, PA). Isotype-matched immunoglobulin G antibodies
(controlisotype,VectorLaboratories,Burlingame,CA,USA)
were incubated in parallel, and the sections were used for
channel-series acquisitions. The light source was an argon
ion laser (25mW) giving excitation wavelength in the re-
gion 458–584nm. FITC was excited at 488nm. Cy3 was
excited at 550nm. Digital images of single optical sections
were acquired using a ×60/oil-immersion objective using
a E2000U inverted confocal microscope (Nikon, Tokyo, Ja-
pan); image sizes were 512 × 512. Negative control cover
slides were set by exposing the seriate sections under similar
conditionsbutwithouttheprimaryantibody.Brightnessand
contrast levels were evaluated using C1 software (Nikon) and
the Adobe Photoshop 7.0 program (Abacus Concepts Inc.,
Berkeley, CA).
2.4. Integrated Optical Density and Statistical Analysis. Den-
sitometric analysis was carried out on images collected with
the same channel series settings by using the C1 confocal
software (Nikon) and then submitted to densitometric an-
alysis using 1D ImageJ software (Image J v1.43; NIH-http://
rsb.info.nih.gov/ij/).Singleintegratedopticaldensity(IntDe-
nsity) was registered for each group.
Data are IntDensity values, expressed as the mean ± SD
(in the text) and mean ± SEM (in the Figure 5). Parametric
ANOVA coupled with Tukey Kramer post hoc analysis was
used to detect signiﬁcant diﬀerence (statistical package Stat-
View II for PC; Abacus Concepts Inc., San Jose, CA, USA). A
P<0.05 was considered statistically signiﬁcant.
3. Results
In the healthy nasal mucosa, both TLR4 and TLR9 were exp-
ressed. As shown in Figures 1(a)–1(c), TLR4 and TLR9 were
detected at the submucosal layer (a), nasal gland (b) and epi-
theliallevel(c).Particularly,aTLR4expression(redstaining)
was mainly localized in the lining epithelial and stromal level
(glandular cells), while TLR9 (green staining) was observed
in the submucosal tissue (stromal level).
Inspecimensobtained fromthepatients suﬀeringbysea-
sonal nasal allergic rhinitis, we detected a lower expression
(−47.5% and −48.9%) of both TLR4 and TLR9 proteins at
the stromal level, as compared to their healthy control values
(201,15±16,61versus382,78±60,44;P<0.05and219,05±
61,65 versus 428,52 ± 116,52; P<0.05; Figures 2(a)–2(c).
Ad i ﬀerent pattern of expression was observed in speci-
mensfrompatientswithchronicrhinosinusitis.Infact,while
the expression of TLR4 was increased by 40.1% versus that
observedinhealthycontrols(536,45±123,50versus382,78 ±
60,44; P<0.05) the expression of TLR9 was decreased by
−23,32% (328,60 ± 41,62 versus 428,52 ± 116,52; P>0.05).
This pattern of expression (Figures 3(a) and 3(b)) was asso-
ciated with a marked structural alteration of the glandular
epithelium with a massive inﬂammatory inﬁltrate showing
a straight TLR4/TLR9 colocalization (resulting in a yellow-
brown colour in the overlay panel).
A similar co-localization of TLR4/TLR was also observed
in vasomotor rhinitis. However, in this phenotype the exp-
ressionofbothTLR4(−39.0%)andTLR9(−63.4%)wassig-
niﬁcantly downregulated as compared to that of healthy con-
trols (233,51 ± 69,47 versus 382,78 ± 60,44; P<0.05 and
157,06 ± 80,56 versus 428,52 ± 116,52; P<0.05, resp.);
Figures 4(a) and 4(b).
ANOVA analysis of IntDen values of allergic rhinitis,
chronic rhinosinusitis, vasomotor rhinitis and healthy con-
trol sections is shown in Figures 5(a) and 5(b).
4. Discussion
This study shows that TLR4 and TLR9 are diﬀerently exp-
ressed in the nasal mucosa of healthy subjects and of the ma-
jor rhinitis phenotypes. Our ﬁndings allow some specula-
tions about the role of TLRs in physiological conditions and
in the diﬀerent inﬂammatory mechanisms responsible for
the diﬀerent forms of rhinitis.
Both TLR4 and TLR9 are expressed in the healthy nasal
mucosa. TLR4 is mainly present in the epithelial layer and in
the glandular cells, while TLR9 is mainly detectable at the
stromal level. In the submucosal layer, TLR4 is present in
scattered cells while the expression of TLR9 is widely diﬀuse.
In the nasal glands, TLR4 was highly expressed while a low-
er expression was shown for TLR9. The observation of a
high TLR4 and TLR9 in the healthy nasal mucosa is con-
sistent with TLR function as the ﬁrst line of defence against
pathogens [7].
Confocal analysis of the inﬂammatory nasal mucosa in
allergic rhinitis revealed a marked downregulation of both
TLR4 and TLR9.International Journal of Otolaryngology 3
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Figure 1: TLR4 and TLR9 expression in healthy turbinates. Confocal analysis showing TLR4 and TLR9 expression at the submucosal layer
(a), nasal glands (b), and at the epithelial level (c). Note the strong TLR4 localization at both the epithelial and stromal levels, while TLR9
was localized at the stromal level. ×60/oil-immersion.
TLR4ismainlyexpressedbydendriticcells,macrophages
and monocytes, as well as by CD3-positive T lymphocytes in
the nasal mucosa of young children [9, 10]. It has been sug-
gested that exposure to microbial products in the early life
induces a shift of the immune response toward a Th1-type
cytokine proﬁle, which protects against the development
of allergies and asthma [11]. In fact, exposure to bacterial
endotoxin—a ligand for TLR4—was shown to be inversely
related to the incidence of atopic asthma, hay fever, and sen-
sitization against aeroallergens in school-aged children [12].
A farming environment is also associated with a lower pre-
valence of both atopic and nonatopic asthma and an increas-
ed exposure to domestic animals implies a decreased atopic
risk [13, 14]. LPS/allergen coexposure resulted in the in-
hibition of allergic inﬂammation and bronchial hyper-re-
sponsiveness, although exposure to LPS after allergen chal-
lenge exacerbated the allergic response [15].
OurﬁndingofalowerTLR4expressioninthenasalmuc-
osaallergicrhinitisisinlinewiththereportedlowexpression
of TLR4 in T cells and the lack of response to LPS in atopic
adults [10, 16].
Endotoxin-rich environments also contain other immu-
nostimulatory microbial products that act as ligands for
TLR2 and TLR9 [17, 18]. While TLR4 is specialized in the re-
cognition of (Gram negative) bacterial products, TLR9 reco-
gnizes unmethylated CpG DNA of bacteria and viruses, as
well as nucleic acids, which are not unique to the micro-
bial world [2]. Synthetic immunostimulatory sequence oli-
godeoxynucleotides(ISS-ODNs)activateTLR9andaremore
eﬀective than steroids in attenuating the hypersensitivity res-
ponse of asthma, allergic conjunctivitis, and allergic rhinitis
[19, 20]. ISS-ODNs rapidly inhibit the activities of eﬀector
Th2 cells and other cells that contribute to allergic response
[16]. Interestingly, vaccination with allergen and ISS-ODN4 International Journal of Otolaryngology
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Figure 2: TLR4 and TLR9 expression in allergic rhinitis. Confocal analysis showing a consistent low expression of TLR4 (a, c) and a reduced
expression of TLR9 at the stromal level (a) and (b), as indicated by a white arrow in (b) ×60/oil-immersion.
and TLR9 ligands has been proposed as a promising ap-
proach in immunotherapy of allergic diseases [16, 19–22].
Therefore, our ﬁnding of a lower expression of TLR4 and
TLR9 in the nasal mucosal of allergic rhinitis patients may be
related to the Th2-type allergic inﬂammation and to the
increased susceptibility to upper respiratory infections usu-
ally observed in rhinitis patients.
In chronic rhinosinusitis we found that TLR4 is signiﬁ-
cantly overexpressed. Our data appear in line with previous
ﬁndings of Dong and coworkers who observed an increased
TLR4 expression in chronic rhinosinusitis epithelial cells
of inferior turbinate nasal mucosa, as compared to healthy
adult volunteers [23]. Accordingly, You and coworkers also
reported a signiﬁcant TLR4 increase in epithelial/glandular
cells of chronic rhinosinusitis, compared to nasal polyps and
control tissues [24]. On the other hand, a low TLR9 exp-
ression has been reported by Ramanatan and coworkers in
chronic rhinosinusitis with nasal polyps patients, in com-
parison to healthy specimens [25, 26].
In rhinosinusitis specimens, confocal analysis showed a
clear TLR4/TLR9 co-localization in the cellular inﬁltrate of
the sub-mucosa associated with marked damage of the epi-
thelium. These ﬁndings are consistent with the chronic in-
ﬂammatory state typical of rhinosinusitis.
Although in vasomotor rhinitis both TLR4 and TLR9 ap-
peared to be signiﬁcantly down-regulated, their co-localiza-
tioninthecellinﬁltratesimilartothatobserved—butinade-
ﬁnitely higher degree—in rhinosinusitis may indicate that a
neurogenic minimal inﬂammation does also occur in this
“noninﬂammatory” rhinitis phenotype [27].
In conclusion, our data indicate that the pattern of exp-
ression of TLR4 and TLR is diﬀerent in healthy subjects and
indiﬀerentformsofrhinitis,possiblyinrelationtothediﬀer-
ent pathophysiological mechanisms involved. These ﬁndingsInternational Journal of Otolaryngology 5
TLR4 TLR9 Merge Densitometry
(a)
(b)
Figure 3: TLR4 and TLR9 expression in chronic rhinitis. Confocal analysis showing the coexpression of TLR4 and TLR9 (a) and (b). Note
the strong structural alteration of the glandular epithelium associated with massive cellular inﬁltrates bearing both TLRs. Asterisk indicates
the lumen of a nasal gland. ×60/oil-immersion.
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Figure 4: TLR4 and TLR9 expression in vasomotor rhinitis. Confocal analysis showing the coexpression of TLR4 and TLR9 (a) and (b).
Note the predominance of the yellow staining indicating the prevalence of the TLR9 expression over TLR4. Asterisk indicates the lumen of a
nasal gland. ×60/oil-immersion.6 International Journal of Otolaryngology
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Figure 5: ANOVA analysis of IntDen values among diﬀerent
subgroups.
may contribute to a more accurate phenotyping of rhinitis
and may suggest new therapeutic approaches based on the
interplay between innate immunity and the adaptive eﬀec-
tor response to allergens and microbial agents.
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